What Dose Do Most People Lose Weight on Ozempic?

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic and Wegovy, works by slowing stomach emptying and signaling fullness to the brain—but the dose that works for one person may differ significantly from another. Clinical trials show that meaningful weight loss typically begins at moderate doses, yet some patients need higher amounts while others achieve results at lower thresholds. Understanding your own dose response depends on your genetics, baseline health status, and how your GLP-1 receptors function.

Typical Semaglutide Dosing Range for Weight Loss

Semaglutide follows a standard titration protocol in most weight-loss programs, starting at 0.25 mg weekly and increasing gradually every four weeks. The maintenance phase typically ranges from 1.7 mg to 2.4 mg weekly, though some patients plateau at lower doses like 0.5 mg or 1.0 mg and achieve their weight-loss goals without advancing further. Clinical data suggests that doses below 0.5 mg may produce appetite suppression but minimal fat loss, while doses above 2.4 mg rarely improve results significantly and increase the risk of gastrointestinal side effects.

Real-world experience shows that approximately 60% of patients experience meaningful weight loss at doses between 1.0 mg and 2.0 mg weekly. The remaining 40% split between those who see results at lower starting doses and those who require the maximum 2.4 mg dose to feel the medication's full effect. This variation underscores why personalized dosing—rather than a one-size-fits-all approach—produces better outcomes and reduces unnecessary medication exposure.

How Genetics Affect Your Semaglutide Response

Your genetic blueprint influences how effectively semaglutide signals hunger suppression and metabolic regulation in your body. Variations in the GLP1R gene (the receptor that semaglutide binds to), the FTO gene (which regulates energy balance), and the MC4R gene (which controls appetite signaling) can shift the dose at which you experience noticeable weight loss. Someone with a genetic variant that reduces GLP1R sensitivity may need a higher dose to achieve the same appetite reduction as someone with standard receptor function.

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and analyzes 49 peptides to reveal your unique genetic predispositions for GLP-1 response. Key variants such as GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 help identify whether you're likely to be a fast responder, a slow responder, or someone who needs a combination therapy approach. This genetic roadmap allows your care team to recommend an optimized starting dose and predict which dose increase timeline will work best for your body.

Weight Loss Results Across Different Dose Levels

Clinical trials demonstrate progressive weight loss as semaglutide doses increase, but the relationship is not always linear. At 0.5 mg weekly, patients lose approximately 3–5% of baseline body weight over 12 weeks. At 1.0 mg weekly, loss increases to roughly 8–10%, and at 2.4 mg weekly, average loss reaches 13–18% depending on diet, exercise, and individual factors. However, these figures represent population averages; individual outcomes vary by 3–5 percentage points in either direction based on genetics and lifestyle adherence.

Importantly, doubling the dose does not always double weight loss. A patient losing 5% of body weight at 1.0 mg may only lose an additional 3–4% after increasing to 2.4 mg, suggesting a plateau effect around higher doses. This is why many practitioners now emphasize finding the minimum effective dose for each patient—the lowest dose producing sustainable weight loss—rather than automatically advancing to maximum doses. This approach reduces side effects while maintaining results and aligning with PlexusDx's philosophy that 'your dose may need to go up, but your price won't.'

Choosing the Right Semaglutide Dose for Your Goals

The ideal starting dose for you depends on several factors: your baseline body mass index (BMI), previous experience with appetite suppressants, gastrointestinal sensitivity, and genetic predisposition to drug response. A patient with a BMI of 28 and high genetic sensitivity to GLP-1 may achieve meaningful results at 0.5 mg weekly, while someone with a BMI of 40 and lower genetic receptor sensitivity may need 2.0 mg to feel full. Your healthcare provider should assess these factors during an initial consultation and recommend a customized titration schedule rather than following a rigid protocol.

PlexusDx compounded semaglutide injections start at $149 monthly with no membership fees, HSA/FSA eligibility, and availability across all 50 states—making personalized dosing accessible without insurance barriers. After your first month of treatment, adding PlexusDx's Precision Peptide Genetic Test for $99 provides concrete data about your peptide-pathway genetics and helps refine your dose optimization strategy. This combination of affordability and precision testing empowers you to work with your care team to find the exact dose that delivers weight loss while minimizing side effects.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I need the maximum 2.4 mg dose of semaglutide to lose weight?

No. Approximately 40% of people achieve their weight-loss goals at doses below 2.0 mg weekly, with some responding well to 0.5–1.0 mg. Your optimal dose depends on your genetics, metabolism, and initial BMI. PlexusDx's Precision Peptide Genetic Test can help predict whether you're likely to be a dose-responder or plateau early, allowing your provider to titrate strategically.

What does the research say about dose-dependent weight loss?

Published trials show that weight loss increases incrementally from 0.5 mg to 2.4 mg, but gains slow significantly above 2.0 mg weekly. Most patients achieve 80% of their potential weight loss at moderate doses (1.0–1.7 mg), with higher doses offering diminishing returns. This supports a personalized, conservative titration approach rather than rapid escalation.

How much does PlexusDx compounded semaglutide cost?

PlexusDx compounded semaglutide injections start at $149 per month across all three commitment tiers, with no membership fee or insurance required. The price remains flat regardless of your dose level—your dose may increase, but your monthly cost stays the same. HSA and FSA accounts are eligible, and the service is available in all 50 states.

What are the side effects at higher doses of semaglutide?

Common side effects—nausea, constipation, fatigue—tend to worsen at doses above 2.0 mg weekly, though most patients tolerate them well with gradual titration. Serious side effects are rare but can include pancreatitis or gallbladder issues. Starting at a low dose and increasing slowly allows your body to adapt and helps you find the therapeutic dose with minimal discomfort.

How does the Precision Peptide Genetic Test help determine my ideal semaglutide dose?

PlexusDx's test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes along with 45 other peptide-related markers to reveal your genetic predisposition for appetite regulation and metabolic response. The results guide your care team in recommending a starting dose, titration pace, and whether combination therapy (like GLP-Squared) might work better for your genetics. This $99 add-on after your first month of treatment transforms your dosing strategy from guesswork to precision.

Related Reading

• Ozempic For Losing Weight
• Ozempic For Weight Loss 2
• Ozempic Starting Dose
• Average Weight Loss On Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.